ReP USP - Resultado da busca

Artigo de periodico
DLK1-DIO3 region as a source of tumor suppressor miRNAs in papillary thyroid carcinoma (2024)
Alves, Letícia Ferreira ; Marson, Leonardo Augusto ; Sielski, Micheli Severo ; Vicente, Cristina Pontes; Kimura, Edna Teruko ; Geraldo, Murilo Vieira
Source: Translational Oncology. Unidade: ICB
Subjects: BIOLOGIA CELULAR, MICRORNAS, NEOPLASIAS DA TIREOIDE, CARCINOMA PAPILAR, MATRIZ EXTRACELULAR, TRANSDUÇÃO DE SINAL CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Letícia Ferreira et al. DLK1-DIO3 region as a source of tumor suppressor miRNAs in papillary thyroid carcinoma. Translational Oncology, v. 46, p. 10 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.tranon.2023.101849. Acesso em: 19 nov. 2024.
APA
Alves, L. F., Marson, L. A., Sielski, M. S., Vicente, C. P., Kimura, E. T., & Geraldo, M. V. (2024). DLK1-DIO3 region as a source of tumor suppressor miRNAs in papillary thyroid carcinoma. Translational Oncology, 46, 10 . doi:10.1016/j.tranon.2023.101849
NLM
Alves LF, Marson LA, Sielski MS, Vicente CP, Kimura ET, Geraldo MV. DLK1-DIO3 region as a source of tumor suppressor miRNAs in papillary thyroid carcinoma [Internet]. Translational Oncology. 2024 ; 46 10 .[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.tranon.2023.101849
Vancouver
Alves LF, Marson LA, Sielski MS, Vicente CP, Kimura ET, Geraldo MV. DLK1-DIO3 region as a source of tumor suppressor miRNAs in papillary thyroid carcinoma [Internet]. Translational Oncology. 2024 ; 46 10 .[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.tranon.2023.101849
Artigo de periodico
Thyroid and breast Cancer in 2 sisters with monoallelic mutations in the ataxia telangiectasia mutated (ATM) gene (2022)
Miasaki, Fabíola Yukiko ; Saito, Kelly Cristina ; Yamamoto, Guilherme Lopes ; Boguszewski, César L. ; Carvalho, Gisah Amaral de ; Kimura, Edna Teruko ; Kopp, Peter A.
Source: Journal of the Endocrine Society. Unidade: ICB
Subjects: BIOLOGIA CELULAR, NEOPLASIAS MAMÁRIAS, NEOPLASIAS DA TIREOIDE, MUTAÇÃO GENÉTICA, ATAXIA, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIASAKI, Fabíola Yukiko et al. Thyroid and breast Cancer in 2 sisters with monoallelic mutations in the ataxia telangiectasia mutated (ATM) gene. Journal of the Endocrine Society, v. 6, n. 4, p. 1-4, 2022Tradução . . Disponível em: https://doi.org/10.1210/jendso/bvac026. Acesso em: 19 nov. 2024.
APA
Miasaki, F. Y., Saito, K. C., Yamamoto, G. L., Boguszewski, C. L., Carvalho, G. A. de, Kimura, E. T., & Kopp, P. A. (2022). Thyroid and breast Cancer in 2 sisters with monoallelic mutations in the ataxia telangiectasia mutated (ATM) gene. Journal of the Endocrine Society, 6( 4), 1-4. doi:10.1210/jendso/bvac026
NLM
Miasaki FY, Saito KC, Yamamoto GL, Boguszewski CL, Carvalho GA de, Kimura ET, Kopp PA. Thyroid and breast Cancer in 2 sisters with monoallelic mutations in the ataxia telangiectasia mutated (ATM) gene [Internet]. Journal of the Endocrine Society. 2022 ; 6( 4): 1-4.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1210/jendso/bvac026
Vancouver
Miasaki FY, Saito KC, Yamamoto GL, Boguszewski CL, Carvalho GA de, Kimura ET, Kopp PA. Thyroid and breast Cancer in 2 sisters with monoallelic mutations in the ataxia telangiectasia mutated (ATM) gene [Internet]. Journal of the Endocrine Society. 2022 ; 6( 4): 1-4.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1210/jendso/bvac026
Artigo de periodico
Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we? (2022)
Fuziwara, Cesar Seigi ; Mello, Diego Claro de ; Kimura, Edna Teruko
Source: Cancers. Unidade: ICB
Subjects: BIOLOGIA CELULAR, NEOPLASIAS DA TIREOIDE, CÉLULAS CULTIVADAS DE TUMOR, GENES, GENES, GENOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUZIWARA, Cesar Seigi e MELLO, Diego Claro de e KIMURA, Edna Teruko. Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we?. Cancers, v. 14, n. 3, p. 1-21, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14030844. Acesso em: 19 nov. 2024.
APA
Fuziwara, C. S., Mello, D. C. de, & Kimura, E. T. (2022). Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we? Cancers, 14( 3), 1-21. doi:10.3390/cancers14030844
NLM
Fuziwara CS, Mello DC de, Kimura ET. Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we? [Internet]. Cancers. 2022 ; 14( 3): 1-21.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3390/cancers14030844
Vancouver
Fuziwara CS, Mello DC de, Kimura ET. Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we? [Internet]. Cancers. 2022 ; 14( 3): 1-21.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3390/cancers14030844
Artigo de periodico
Targeting the highly expressed microRNA miR-146b with CRISPR/Cas9n gene editing system in thyroid cancer (2021)
Inez, Daniel Casartelli de Santa ; Fuziwara, Cesar Seigi ; Saito, Kelly Cristina ; Kimura, Edna Teruko
Source: International Journal of Molecular Sciences. Unidade: ICB
Subjects: BIOLOGIA CELULAR, NEOPLASIAS DA TIREOIDE, MICRORNAS, GENES SUPRESSORES DE TUMOR, CÉLULAS CULTIVADAS DE TUMOR, CAMUNDONGOS, SEQUENCIAMENTO GENÉTICO, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
INEZ, Daniel Casartelli de Santa et al. Targeting the highly expressed microRNA miR-146b with CRISPR/Cas9n gene editing system in thyroid cancer. International Journal of Molecular Sciences, v. 22, n. 15, p. 1-14, 2021Tradução . . Disponível em: https://doi.org/10.3390/ijms22157992. Acesso em: 19 nov. 2024.
APA
Inez, D. C. de S., Fuziwara, C. S., Saito, K. C., & Kimura, E. T. (2021). Targeting the highly expressed microRNA miR-146b with CRISPR/Cas9n gene editing system in thyroid cancer. International Journal of Molecular Sciences, 22( 15), 1-14. doi:10.3390/ijms22157992
NLM
Inez DC de S, Fuziwara CS, Saito KC, Kimura ET. Targeting the highly expressed microRNA miR-146b with CRISPR/Cas9n gene editing system in thyroid cancer [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 15): 1-14.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3390/ijms22157992
Vancouver
Inez DC de S, Fuziwara CS, Saito KC, Kimura ET. Targeting the highly expressed microRNA miR-146b with CRISPR/Cas9n gene editing system in thyroid cancer [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 15): 1-14.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3390/ijms22157992

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Non normalized affiliation